FDA approves Bristol Myers' heart disease drug

Posted on
FILE PHOTO: A woman holds test tube in front of displayed Bristol Myers Squibb logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration

(Reuters) – Drugmaker Bristol Myers Squibb said on Thursday the U.S. Food and Drug Administration had approved its oral drug mavacamten for the treatment of a heart condition.

Source: Read Full Article

Related posts:
  1. Neanderthal or Human, Babies Weaned at Same Age
  2. Iran’s daily virus infections top 10,000
  3. Guppy research shows ADHD drugs can affect later generations
  4. Restless legs syndrome is a sleep wrecking nightmare
  5. Certain dietary patterns may raise risk for developing IBD
Related posts